{
    "clinical_study": {
        "@rank": "63885", 
        "acronym": "CERAM", 
        "arm_group": {
            "arm_group_label": "Total hip replacement using a ceramic friction pair", 
            "description": "Patients treated with total hip replacement using a ceramic friction pair Biolox\u00ae Delta, with Meije Duo\u00ae stem associated with Dynacup\u00ae cup"
        }, 
        "brief_summary": {
            "textblock": "The aim of this study is to assess safety and general performance of total hip arthroplasty,\n      composed of a Meije Duo\u00ae femoral stem associated with a Dynacup\u00ae cup, and using the friction\n      pair Biolox\u00ae Delta Ceramic."
        }, 
        "brief_title": "Clinical and Radiological Results of Total Hip Arthroplasty Using a Ceramic Friction Pair", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": [
            "Hip Replacement", 
            "Primary, Secondary or Post-traumatic Osteoarthrosis", 
            "Femur Head Necrosis", 
            "Congenital Dislocations"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Dislocations", 
                "Femur Head Necrosis", 
                "Joint Diseases", 
                "Osteoarthritis", 
                "Necrosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female patient implanted with a primary total hip replacement using a ceramic\n             friction pair including Meije Duo\u00ae stem associated with a Dynacup\u00ae cup.\n\n          -  Aged of more than 18 years at the time of the surgery.\n\n          -  Patient with a follow-up of at least 2 years after surgery based on a consecutive and\n             exhaustive series of patients operated within the inclusion period.\n\n          -  Able to understand information to participate to the study.\n\n        Exclusion Criteria:\n\n          -  Patient having a tumoral pathology.\n\n          -  Patient having expressed opposition to the study participation."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Cohort of European patients with a primary total hip replacement using a ceramic friction\n        pair including Meije Duo\u00ae stem associated with a Dynacup\u00ae cup."
            }
        }, 
        "enrollment": {
            "#text": "132", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 12, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02062437", 
            "org_study_id": "1301-T-CERAM-R"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Arthroplasty", 
            "Hip Replacement", 
            "Ceramic", 
            "Acetabular cup", 
            "Femoral stem"
        ], 
        "lastchanged_date": "February 12, 2014", 
        "number_of_groups": "1", 
        "official_title": "Multicentric Observational Study Evaluating Clinical and Radiological Results of a Total Hip Arthroplasty Using a Ceramic Friction Pair", 
        "other_outcome": [
            {
                "description": "Postel Merle d'Aubigne (PMA) rating contains three items; pain, function and hip mobility; each noted 6 points (18 is the best score).", 
                "measure": "General performance: objective clinical score (PMA)", 
                "safety_issue": "No", 
                "time_frame": "2-year Follow-up visit"
            }, 
            {
                "description": "Radiological assessment is based on :\nCup radiological signs.\nStem radiological signs.\nOssifications", 
                "measure": "General performance: Radiological assessment.", 
                "safety_issue": "No", 
                "time_frame": "2-year Follow-up visit"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "France: Minist\u00e8re de l'Enseignement sup\u00e9rieur et de la Recherche", 
                "France: The Commission nationale de l\u2019informatique et des libert\u00e9s"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Surgical incidents.\nPost-operative complications.\nFailure and revisions analysis.", 
            "measure": "Adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "2-year follow-up visit"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02062437"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Mobility is assessed by the measurement of the degree of amplitude of: extension, flexion, abduction, adduction, external rotation and internal rotation of the hip.", 
            "measure": "General performance: Mobility", 
            "safety_issue": "No", 
            "time_frame": "2-year Follow-up visit"
        }, 
        "source": "Tornier", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tornier", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}